La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
GC Biopharma Résultats passés
Passé contrôle des critères 0/6
Informations clés
1.1%
Taux de croissance des bénéfices
9.9%
Taux de croissance du BPA
Biotechs Croissance de l'industrie | 11.7% |
Taux de croissance des recettes | 5.2% |
Rendement des fonds propres | -1.9% |
Marge nette | -1.8% |
Dernière mise à jour des bénéfices | 31 Mar 2024 |
Mises à jour récentes des performances passées
Recent updates
There's No Escaping GC Biopharma Corp.'s (KRX:006280) Muted Revenues
Aug 02A Look At The Fair Value Of GC Biopharma Corp. (KRX:006280)
Jul 12Is GC Biopharma (KRX:006280) A Risky Investment?
May 25GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry
Mar 08We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt
May 02Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?
Mar 10Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%
Feb 18Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet
Jan 31Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)
Jan 14What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition
Dec 27Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 09Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 21Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment GC Biopharma gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Mar 24 | 1,633,972 | -29,491 | 261,695 | 161,699 |
31 Dec 23 | 1,626,644 | -26,632 | 262,217 | 173,487 |
30 Sep 23 | 1,633,172 | 1,858 | 280,061 | 191,908 |
30 Jun 23 | 1,653,489 | 25,441 | 283,991 | 200,965 |
31 Mar 23 | 1,643,852 | 36,611 | 291,422 | 205,175 |
31 Dec 22 | 1,711,313 | 65,453 | 295,284 | 191,347 |
30 Sep 22 | 1,702,128 | 108,541 | 297,800 | 180,583 |
30 Jun 22 | 1,708,169 | 124,737 | 298,750 | 173,838 |
31 Mar 22 | 1,672,535 | 114,840 | 298,563 | 151,949 |
31 Dec 21 | 1,537,826 | 123,212 | 289,761 | 146,030 |
30 Sep 21 | 1,552,271 | 86,257 | 277,318 | 146,836 |
30 Jun 21 | 1,506,143 | 93,472 | 266,822 | 136,059 |
31 Mar 21 | 1,478,566 | 99,854 | 247,721 | 138,285 |
31 Dec 20 | 1,504,115 | 80,886 | 243,368 | 137,987 |
30 Sep 20 | 1,438,540 | 44,131 | 229,689 | 124,886 |
30 Jun 20 | 1,385,465 | 7,169 | 219,727 | 123,136 |
31 Mar 20 | 1,381,597 | -8,068 | 207,686 | 125,411 |
31 Dec 19 | 1,357,117 | 1,341 | 195,548 | 126,673 |
30 Sep 19 | 1,352,625 | 21,663 | 178,769 | 123,265 |
30 Jun 19 | 1,338,420 | 14,322 | 172,058 | 125,012 |
31 Mar 19 | 1,324,106 | 23,943 | 169,005 | 124,159 |
31 Dec 18 | 1,334,878 | 34,429 | 167,043 | 122,029 |
30 Sep 18 | 1,314,527 | 32,485 | 167,922 | 121,125 |
30 Jun 18 | 1,318,285 | 42,928 | 167,117 | 117,807 |
31 Mar 18 | 1,306,606 | 64,339 | 164,046 | 112,764 |
31 Dec 17 | 1,287,916 | 53,247 | 161,412 | 108,639 |
30 Sep 17 | 1,282,593 | 76,100 | 155,259 | 112,519 |
30 Jun 17 | 1,254,113 | 71,435 | 153,044 | 113,156 |
31 Mar 17 | 1,227,485 | 62,300 | 154,949 | 113,861 |
31 Dec 16 | 1,197,904 | 62,970 | 154,677 | 112,283 |
30 Sep 16 | 1,146,958 | 40,707 | 155,375 | 112,607 |
30 Jun 16 | 1,114,394 | 75,617 | 151,820 | 104,441 |
31 Mar 16 | 1,079,274 | 87,817 | 146,660 | 100,021 |
31 Dec 15 | 1,047,812 | 94,967 | 142,875 | 98,210 |
30 Sep 15 | 1,035,748 | 96,613 | 139,435 | 86,319 |
30 Jun 15 | 1,023,133 | 84,250 | 136,491 | 82,718 |
31 Mar 15 | 990,420 | 68,220 | 132,621 | 77,561 |
31 Dec 14 | 975,327 | 83,945 | 131,217 | 76,990 |
30 Sep 14 | 959,764 | 86,914 | 124,781 | 76,210 |
30 Jun 14 | 937,735 | 75,576 | 122,349 | 77,998 |
31 Mar 14 | 908,456 | 79,108 | 119,907 | 76,388 |
31 Dec 13 | 888,168 | 70,066 | 117,396 | 73,615 |
30 Sep 13 | 839,892 | 62,325 | 113,236 | 81,391 |
Augmentation de la marge bénéficiaire: A006280 n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: A006280 n'est pas rentable, mais a réduit ses pertes au cours des 5 dernières années à un taux de 1.1% par an.